Childhood Trauma Predicts Less Remission from PTSD among Patients with Co-Occurring Alcohol Use Disorder and PTSD.

Substance-use disorder addictive disorders alcohol use disorder childhood trauma dual disorders impulsive behavior post-traumatic stress disorder psychiatric disorders rehabilitation centers substance-related disorders

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
30 Jun 2020
Historique:
received: 05 05 2020
revised: 16 06 2020
accepted: 27 06 2020
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 8 7 2020
Statut: epublish

Résumé

Post-traumatic stress disorder (PTSD) is highly prevalent among patients hospitalized for an alcohol use disorder (AUD). Hospitalization can improve PTSD and AUD outcomes in some but not all patients, but we lack data on the baseline predictors of PTSD non-remission. This study aimed to determine the baseline risk factors for non-remitted PTSD in patients hospitalized for an AUD. Of 298 AUD inpatients recruited in a rehabilitation center (Le Courbat, France), we included 91 AUD inpatients with a co-occurring PTSD and a longitudinal assessment at baseline (T1) and before discharge (T2: 8 weeks later). Patients were assessed for PTSD diagnosis/severity (PCL-5=PTSD Checklist for DSM-5), different types of trauma including childhood trauma (LEC-5=Life Events Checklist for DSM-5/CTQ-SF=Childhood Trauma Questionnaire, Short-Form), and AUD diagnosis/severity (clinical interview/AUDIT=Alcohol Use Disorders Identification Test). Rate of PTSD remission between T1 and T2 was 74.1%. Non-remitted PTSD at T2 was associated with a history of childhood trauma (physical, emotional or sexual abuse, physical negligence), but not with other types of trauma experienced, nor baseline PTSD or AUD severity. Among patients hospitalized for an AUD with co-occurring PTSD, PTSD remission was more strongly related to the existence of childhood trauma than to AUD or PTSD severity at admission. These patients should be systematically screened for childhood trauma in order to tailor evidence-based interventions.

Identifiants

pubmed: 32629872
pii: jcm9072054
doi: 10.3390/jcm9072054
pmc: PMC7408730
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : University Hospital of Tours
ID : No grant number (funding for english revision of the manuscript)

Références

Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Arch Gen Psychiatry. 1995 Dec;52(12):1048-60
pubmed: 7492257
Alcohol Res. 2012;34(4):408-13
pubmed: 23584107
J Subst Abuse Treat. 2011 Sep;41(2):186-92
pubmed: 21546205
Psychol Assess. 2014 Sep;26(3):717-29
pubmed: 24773037
J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
JAMA. 2000 Apr 12;283(14):1837-44
pubmed: 10770145
Drug Alcohol Rev. 2012 May;31(3):294-302
pubmed: 21521385
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
Depress Anxiety. 2020 Apr;37(4):365-374
pubmed: 31999402
Nord J Psychiatry. 2015;69(7):483-96
pubmed: 25733025
J Anxiety Disord. 2015 Oct;35:103-17
pubmed: 26409250
Subst Use Misuse. 2012 Jun-Jul;47(8-9):1005-14
pubmed: 22676568
Sante Ment Que. 2004 Spring;29(1):201-20
pubmed: 15470573
Child Abuse Negl. 2015 Aug;46:8-15
pubmed: 25828861
Am J Addict. 2018 Jan;27(1):23-28
pubmed: 29251380
Lancet. 2019 Aug 31;394(10200):781-792
pubmed: 31478502
Clin Psychol Rev. 2014 Apr;34(3):249-55
pubmed: 24681171
BMC Psychiatry. 2017 Mar 16;17(1):95
pubmed: 28302084
J Nerv Ment Dis. 2006 Sep;194(9):690-6
pubmed: 16971821
Curr Opin Psychiatry. 2007 Nov;20(6):614-8
pubmed: 17921765
Dialogues Clin Neurosci. 2017 Jun;19(2):159-168
pubmed: 28867940
Lancet. 2009 Jun 27;373(9682):2223-33
pubmed: 19560604
Psychol Med. 2018 Feb;48(3):437-450
pubmed: 28720167
Addiction. 2013 Aug;108(8):1397-1410
pubmed: 25328957
J Psychosom Res. 2017 Jun;97:63-69
pubmed: 28606501
Psychol Addict Behav. 2018 Mar;32(2):224-229
pubmed: 29553778
J Trauma Stress. 2010 Jun;23(3):376-83
pubmed: 20564371
J Clin Psychopharmacol. 2002 Apr;22(2):190-5
pubmed: 11910265
Drug Alcohol Depend. 2013 Oct 1;132(3):630-8
pubmed: 23702490
Addict Behav. 2018 Jan;76:188-194
pubmed: 28846939
Behav Sci (Basel). 2014 Dec 08;4(4):511-527
pubmed: 25494488
Psychol Addict Behav. 2017 May;31(3):326-335
pubmed: 28263624
Depress Anxiety. 2010 Dec;27(12):1077-86
pubmed: 21049532
Alcohol Clin Exp Res. 2012 Jun;36(6):1099-107
pubmed: 22420670
Subst Use Misuse. 2018 Mar 21;53(4):677-685
pubmed: 28952825
Psychol Med. 2012 Aug;42(8):1695-703
pubmed: 22166813
Addict Behav. 2007 May;32(5):902-11
pubmed: 16857322
PLoS One. 2016 Oct 10;11(10):e0161645
pubmed: 27723815
Psychiatr Danub. 2018 Sep;30(3):340-347
pubmed: 30267527
Alcohol Clin Exp Res. 2005 Nov;29(11):2001-7
pubmed: 16340457
Psychiatry Res. 2018 Feb;260:262-271
pubmed: 29220684

Auteurs

Paul Brunault (P)

CHRU de Tours, Service d'Addictologie Universitaire, Équipe de Liaison et de Soins en Addictologie, 37044 Tours, France.
CHRU de Tours, Clinique Psychiatrique Universitaire, 37044 Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37020 Tours, France.
Qualipsy EE 1901, Université de Tours, 37020 Tours, France.

Kevin Lebigre (K)

CHRU de Tours, Service d'Addictologie Universitaire, Équipe de Liaison et de Soins en Addictologie, 37044 Tours, France.
CHRU de Tours, Clinique Psychiatrique Universitaire, 37044 Tours, France.

Fatima Idbrik (F)

Soins de Suite et de Réadaptation en Addictologie "Le Courbat", 37460 Le Liège, France.

Damien Maugé (D)

CHRU de Tours, Service d'Addictologie Universitaire, Équipe de Liaison et de Soins en Addictologie, 37044 Tours, France.
CHRU de Tours, Centre de Soins d'Accompagnement et de Prévention en Addictologie CSAPA-37, 37044 Tours, France.

Philippe Adam (P)

Soins de Suite et de Réadaptation en Addictologie "Le Courbat", 37460 Le Liège, France.

Servane Barrault (S)

Qualipsy EE 1901, Université de Tours, 37020 Tours, France.
CHRU de Tours, Centre de Soins d'Accompagnement et de Prévention en Addictologie CSAPA-37, 37044 Tours, France.

Grégoire Baudin (G)

Qualipsy EE 1901, Université de Tours, 37020 Tours, France.
Laboratory of Psychopathology and Health Processes EA 4057, University Paris Descartes, Sorbonne Paris Cité, 92100 Boulogne-Billancourt, France.

Robert Courtois (R)

CHRU de Tours, Clinique Psychiatrique Universitaire, 37044 Tours, France.
Qualipsy EE 1901, Université de Tours, 37020 Tours, France.

Hussein El Ayoubi (H)

CHRU de Tours, Service d'Addictologie Universitaire, Équipe de Liaison et de Soins en Addictologie, 37044 Tours, France.
CHRU de Tours, Centre de Soins d'Accompagnement et de Prévention en Addictologie CSAPA-37, 37044 Tours, France.

Marie Grall-Bronnec (M)

Addictology and Psychiatry Department, Hôpital Saint Jacques, University Hospital of Nantes, 85 rue Saint Jacques, Cedex 1, 44093 Nantes, France.
Inserm, SPHERE U1246 «methodS in Patients-centered outcomes and HEalth ResEarch», Université de Nantes, Université de Tours, 22 boulevard Benoni Goullin, 44200 Nantes, France.

Coraline Hingray (C)

Pôle Universitaire du Grand Nancy, Centre Psychothérapique de Nancy, 54520 Laxou, France.

Nicolas Ballon (N)

CHRU de Tours, Service d'Addictologie Universitaire, Équipe de Liaison et de Soins en Addictologie, 37044 Tours, France.
CHRU de Tours, Clinique Psychiatrique Universitaire, 37044 Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37020 Tours, France.

Wissam El-Hage (W)

CHRU de Tours, Clinique Psychiatrique Universitaire, 37044 Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37020 Tours, France.

Classifications MeSH